News and Events
See us at Medica 2013 in partnership with Lynton Lasers, LumaCare’s UK Distributor.
NOVEMBER 20th – 23rd 2013
LumaCare will be sponsoring the Annual VCS Conference in Las Vegas, NV
OCTOBER 17th – 19th, 2013
American Academy of Dermatology – 71h Annual Meeting in Miami Beach, FL
MARCH 16th – 20th, 2013
See LumaCare in 2008 At:
American Academy of Dermatology – 66th Annual Meeting – February 1-5, 2008
San Antonio, TX www.aad.org/meetings
LumaCare will be sponsoring the 28th Annual VCS Conference in Seattle Washington, at the Westin October 18- 21, 2008 www.vetcancersociety.org
See us at Medica 2008 in partnership with Lynton Lasers, LumaCare’s UK Distributor. www.medica.de Show Dates 19 – 22 November, 2008
MOST CURRENT LUMACARE PRESS RELEASES:
Feb 6, 2007 – NEW!
LumaCare® EPO Grant Patent!
…Read More
Feb, 2007 – NEW!
LumaCare® is now FDA Approved!
…Read More
Jan 15, 2007 – NEW!
LumaCare® has developed an illumination source for Photodynamic Therapy that is simple, elegant, safe and cost effective.
…Read More
Jan 7, 2007 – NEW!
LumaCare® has developed an illumination source for Photodynamic Therapy that is simple, elegant, safe and cost effective.
…Read More
Feb 28, 2006
The LumaCare® Appoints Lynton Lasers Ltd., as the official Master Distributor for European Union. Lynton Lasers currently distributes medical lasers and IPL light sources into the cosmetic, medical and aesthetic market.
…Read More
Sept 06, 2005
The LumaCare® LC-122M receives the coveted European CE Medical Device approval. Ci-Tec, Ltd., a subsidiary of MBG Technologies, Inc., today announces the LC-122M non-coherent PDT activation device has received CE Medical approval. The approvals include Protocol usage of the LC-122M to activate Photodynamic Drugs such as: ALA, 5-ALA, Foscan®, Levulan®, Metex®, Photofrin®, and others.
…Read More
March 30, 2004
Lumacare(r) announces that the LC-122M non-coherent PDT activation device has received CE Medical approval. The approval stems from the usage of the LC-122M to activate Photodynamic protocols such as: ALA, 5-ALA, Foscan®, Levulan®, Metvix®, Photofrin®, and others, “We have finally proven that a non-coherent light source can activate PDT protocols without an expensive, potentially dangerous laser.”
…Read More
© 1996-2013 MBG Technologies